NOVAVAX BARR into Symmetric traingle

NASDAQ:NVAX   Novavax, Inc
first of all thanks for stopping by.. This text below will be posted on every timeframe
Until now, not much was known about Novavax because it was Moderna or Pfizer what was on the news and media, but now NOVAVAX has been in the news and so that's why the chart popped up on my radar .

On the big picture I'm looking at the 2 monthly chart
To remove some noise and get a good idea of ​​the price, I find a DRABW Right Angled Descending Broadening Wedge here, often a Bullish pattern . At the top we see that another support line has been found where the bulls can prepare themself to make an attempt to attack the upper resistance / ATH again. see also in this picture the divergence that has managed to make a considerable run up. Here it is also nice to see how the share price reacts to favorable news for a company like this.

To stay in the even number, we zoom in slightly to the 2W chart.
here we see very nicely how a Bump and Run is rejected on the 0.382 of the fibonacci, the price just looks up the trend channel and from there the bulls make another attack on the resistance line (Lead-in) and with succes. So mirroring the pattern could give an idea for where it could go .. and so we have now ended up in a symmetrical triangle i even think that in an EW count, this could be an Ending diagonal or a correction wave. and after a corrective wave comes another impulse wave (up or down).

Ending with the day chart. zoomed in on the symmetrical triangle.
good to see how the pressure is on the top in the pattern. and the picture is how the situation is. you could even spot a fractal white squares and if it would continue, which means that it could happen again. So keep an eye out and look for supporting within the pattern.

Keep calm, do your own research! trade safe and manage your risk.
*(Disclaimer: This is not financial advice)


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.